244 related articles for article (PubMed ID: 19659704)
21. Daily antibiotic cost of nosocomial infections in a Turkish university hospital.
Inan D; Saba R; Gunseren F; Ongut G; Turhan O; Yalcin AN; Mamikoglu L
BMC Infect Dis; 2005 Jan; 5():5. PubMed ID: 15679899
[TBL] [Abstract][Full Text] [Related]
22. Economic analysis of nosocomial infections in a Turkish university hospital.
Yalçin AN; Hayran M; Unal S
J Chemother; 1997 Dec; 9(6):411-4. PubMed ID: 9491840
[TBL] [Abstract][Full Text] [Related]
23. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention.
Jarvis WR
Infect Control Hosp Epidemiol; 1996 Aug; 17(8):552-7. PubMed ID: 8875302
[TBL] [Abstract][Full Text] [Related]
24. Catheter-associated bloodstream infections: looking outside of the ICU.
Marschall J
Am J Infect Control; 2008 Dec; 36(10):S172.e5-8. PubMed ID: 19084150
[TBL] [Abstract][Full Text] [Related]
25. CDC central-line bloodstream infection prevention efforts produced net benefits of at least $640 Million during 1990-2008.
Scott RD; Sinkowitz-Cochran R; Wise ME; Baggs J; Goates S; Solomon SL; McDonald LC; Jernigan JA
Health Aff (Millwood); 2014 Jun; 33(6):1040-7. PubMed ID: 24889954
[TBL] [Abstract][Full Text] [Related]
26. Embracing collaboration: a novel strategy for reducing bloodstream infections in outpatient hemodialysis centers.
Lindberg C; Downham G; Buscell P; Jones E; Peterson P; Krebs V
Am J Infect Control; 2013 Jun; 41(6):513-9. PubMed ID: 23219669
[TBL] [Abstract][Full Text] [Related]
27. Cost of nosocomial infection in Turkey: an estimate based on the university hospital data.
Khan MM; Celik Y
Health Serv Manage Res; 2001 Feb; 14(1):49-54. PubMed ID: 11246784
[TBL] [Abstract][Full Text] [Related]
28. Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs.
Vrijens F; Hulstaert F; Van de Sande S; Devriese S; Morales I; Parmentier Y
J Hosp Infect; 2010 Jul; 75(3):158-62. PubMed ID: 20381900
[TBL] [Abstract][Full Text] [Related]
29. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?
Ben-David D; Novikov I; Mermel LA
Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266
[TBL] [Abstract][Full Text] [Related]
30. Attributable cost of nosocomial primary bloodstream infection in pediatric intensive care unit patients.
Elward AM; Hollenbeak CS; Warren DK; Fraser VJ
Pediatrics; 2005 Apr; 115(4):868-72. PubMed ID: 15805357
[TBL] [Abstract][Full Text] [Related]
31. An economic model to assess the cost and benefits of the routine use of silver alloy coated urinary catheters to reduce the risk of urinary tract infections in catheterized patients.
Plowman R; Graves N; Esquivel J; Roberts JA
J Hosp Infect; 2001 May; 48(1):33-42. PubMed ID: 11358469
[TBL] [Abstract][Full Text] [Related]
32. The impact of nosocomial infections on hospital care costs.
Lauria FN; Angeletti C
Infection; 2003 Dec; 31 Suppl 2():35-43. PubMed ID: 15018471
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology, surveillance, and prevention of bloodstream infections in hemodialysis patients.
Patel PR; Kallen AJ; Arduino MJ
Am J Kidney Dis; 2010 Sep; 56(3):566-77. PubMed ID: 20554361
[TBL] [Abstract][Full Text] [Related]
34. Costs associated with hospital-acquired bacteraemia in a Belgian hospital.
Pirson M; Dramaix M; Struelens M; Riley TV; Leclercq P
J Hosp Infect; 2005 Jan; 59(1):33-40. PubMed ID: 15571851
[TBL] [Abstract][Full Text] [Related]
35. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs.
Orsi GB; Di Stefano L; Noah N
Infect Control Hosp Epidemiol; 2002 Apr; 23(4):190-7. PubMed ID: 12002233
[TBL] [Abstract][Full Text] [Related]
36. Cost-benefit analysis of craniocerebral surgical site infection control in tertiary hospitals in China.
Zhou J; Ma X
J Infect Dev Ctries; 2015 Feb; 9(2):182-9. PubMed ID: 25699493
[TBL] [Abstract][Full Text] [Related]
37. National influences on catheter-associated bloodstream infection rates: practices among national surveillance networks participating in the European HELICS project.
Hansen S; Schwab F; Behnke M; Carsauw H; Heczko P; Klavs I; Lyytikäinen O; Palomar M; Riesenfeld Orn I; Savey A; Szilagyi E; Valinteliene R; Fabry J; Gastmeier P
J Hosp Infect; 2009 Jan; 71(1):66-73. PubMed ID: 18799236
[TBL] [Abstract][Full Text] [Related]
38. Effect of an infection control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina.
Rosenthal VD; Guzman S; Pezzotto SM; Crnich CJ
Am J Infect Control; 2003 Nov; 31(7):405-9. PubMed ID: 14639436
[TBL] [Abstract][Full Text] [Related]
39. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections.
Blot SI; Depuydt P; Annemans L; Benoit D; Hoste E; De Waele JJ; Decruyenaere J; Vogelaers D; Colardyn F; Vandewoude KH
Clin Infect Dis; 2005 Dec; 41(11):1591-8. PubMed ID: 16267731
[TBL] [Abstract][Full Text] [Related]
40. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.
Wisplinghoff H; Bischoff T; Tallent SM; Seifert H; Wenzel RP; Edmond MB
Clin Infect Dis; 2004 Aug; 39(3):309-17. PubMed ID: 15306996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
